E-Prescribing Market Size, Status, Global Outlook 2023 To 2030
The E-Prescribing Market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The Global E-Prescribing Market Size Was Estimated At USD 2.89 Billion In 2022 And It Is Anticipated To Witness A CAGR Of 26.8% During The Forecast Period.
Top Companies in the Global E-Prescribing Market are:
Cerner Corporation (Oracle), Allscripts Healthcare, LLC, Epic Systems Corporation, DrFirst, Athenahealth, NXGN Management, LLC, McKesson Corporation, Surescripts, Change Healthcare, Practice Fusion, Inc., Networking Technology, Inc., Others
Click Here to Get A Free Sample PDF Copy Of The Latest Research on E-Prescribing Market 2023 Before Purchase@
https://www.contrivedatuminsights.com/request-sample/248465/
Market Overview
The market is anticipated to expand since more individuals are utilizing electronic prescribing for controlled substances (EPSC) and the government is enacting market-friendly rules. In October 2018, Congress passed the SUPPORT for Patients and Communities Act (H.R. 6). By January 1, 2021, all controlled substances covered by Medicare Part D must be dispensed electronically, under this law. Additionally, the industry is anticipated to expand as more individuals become concerned about patient safety. During the COVID-19 pandemic, hospitals and other healthcare facilities were required to alter their practices to prevent the spread of illness among the general public and healthcare personnel. E-prescribing solutions grew in popularity as a result of their ability to facilitate patients' access to their prescribed medications. During the epidemic, the market experienced significant expansion. In 2020, for instance, Surescripts had more than one million prescribers using e-Prescriptions.In recent years, new growth activities, product approvals, product launches, collaborations, and acquisitions have aided the e-prescribing sector. In August 2021, for instance, the India-based health firm Meddo acquired the e-prescription platform Doxper.
This report segments the global E-Prescribing Market:
• Support
• Implementation
• Training
• Network
By Usage Methods:
• Handheld
• Computer Based Devices
• Others
By End-use:
• Hospital
• Office-based Physicians
• Pharmacy
• Others
By Substances:
• Controlled Substances
• Non-controlled Substances
• Others
By Specialties:
• Oncology
• Sports Medicine
• Neurology
• Cardiology
• Others
Buy Now This Report
https://www.contrivedatuminsights.com/buy/248465
Regional Analysis of E-Prescribing Market:
The North American market is the largest for e-prescribing. North America contributed around 44% of the world's revenue in 2022. The proliferation of government programs and incentives in this region is primarily responsible for its expansion. The second-largest market for e-prescription software is Europe. This is because European nations have implemented stringent regulations to prevent medical errors. Additionally, EU-initiated projects are projected to stimulate economic growth in the region.In 2019, the EU issued a circular stating that an e-prescription from a doctor in a different EU country can be used at a pharmacy in another EU member state. During the period covered by the forecast, the Asia-Pacific region is anticipated to develop the most rapidly, by almost 30%. This expansion is the result of more individuals using technology and greater disposable income in the region.
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
Finally, the E-Prescribing Market report is a believable source for gaining market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request and market development rate and figure and so on. E-Prescribing industry report additionally Presents a new task SWOT examination, speculation attainability investigation, and venture return investigation.
KEY HIGHLIGHTS OF THE REPORT
– Quantitative market information and forecasts for the global E-Prescribing industry, segmented by type, end use, and geographic region.
– Expert analysis of the key technological, demographic, economic, and regulatory factors driving growth in E-Prescribing to 2030
– Market opportunities and recommendations for new investments.
– Growth prospects among emerging nations through 2030
About Us:
Contrive Datum Insights (CDI) is a global delivery partner of market intelligence and consulting services to officials in various sectors such as investment, information technology, telecommunication, consumer technology, and manufacturing markets. CDI assists investment communities, business executives, and IT professionals to undertake statistics-based accurate decisions on technology purchases and advance strong growth tactics to sustain market competitiveness. Comprising of a team size of more than 100 analysts and cumulative market experience of more than 200 years, Contrive Datum Insights guarantees the delivery of industry knowledge combined with global and country-level expertise.
Contact Us@:
Anna B. | Head Of Sales
Contrive Datum Insights
Phone: +91 9834816757 | +1 2152974078
Email: anna@conrivedatuminsights.com